NCT03779399View on ClinicalTrials.gov

Treg, Th17 Cells, NKT in Epithelial Ovarian Tumor

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

December 1, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

December 31, 2016

Conditions
Ovarian CancerBorderline Ovarian TumorsBenign Ovarian TumorUnexplained Infertility
Interventions
OTHER

Assessment of percentage of Treg, Th17, NKT and serum level of HE4, CA125 and ROMA.

Treg, Th17, NKT cells in peripheral blood and ovarian tissue and serum level of HE4, CA125 and ROMA.

Trial Locations (1)

20-954

IInd Department of Gynecology, Lublin

All Listed Sponsors
lead

Medical University of Lublin

OTHER

NCT03779399 - Treg, Th17 Cells, NKT in Epithelial Ovarian Tumor | Biotech Hunter | Biotech Hunter